OPEN LUNG-BIOPSY PROVIDES A HIGHER AND MORE SPECIFIC DIAGNOSTIC YIELDCOMPARED TO BRONCHOALVEOLAR LAVAGE IN IMMUNOCOMPROMISED PATIENTS

In order to examine the feasibility and safety of undertaking a larger prospective study to compare the diagnostic yield from concurrent ope n lung biopsy (OLB) and bronchoalveol ar lavage (BAL) in febrile neutr openic patients with pulmonary infiltrates and the impact of such know ledge on clinical outcome, a pilot exploratory study was performed. 13 immunocompromised patients (mainly with haematological malignancy or bone marrow transplantation recipients) were investigated. At least on e diagnostic finding in 12 of 13 patients was provided by OLB compared to 4 of 13 patients by BAL. BAL provided 7 specific diagnoses (pneumo cystis 1, fungal infection 3, bacterial pneumonia 1, pulmonary haemorr hage 2) whilst OLB provided 12 specific diagnosis (CMV 2, pneumocystis 3, fungal infection 1, bacterial pneumonia 1, pulmonary haemorrhage 4 , pulmonary embolism 1). Five patients with nonspecific interstitial/a lveolar inflammation were diagnosed only by OLB. The concordance that the exact same specific diagnoses present in the OLB were found in the BAL was zero. There were 2 minor complications (1 wound infection by OLB, 1 moderate haemorrhage by BAL). Mortality at 28 days was 8 of 13 patients which in no case was related to either procedure. We suggest that OLB is a safe procedure in such patients, provides superior and m ore complete diagnostic information compared to BAL and a larger contr olled study to investigate the impact of early OLB on the outcome of t hese patients appears to be justified.